Latest Equities News

Green Technology Metals (ASX: GT1) secures A$11 million to complete feasibility studies and permitting for its Seymour Lithium Project, aiming for first ore in 2028 amid a recovering lithium market and strong Canadian support.

Jayride Group continues its pivot to a SaaS mobility platform across Australasia and Southeast Asia, managing tight cash flow and planning a capital raise to sustain operations and support ASX reinstatement.

VanEck Investments Limited has released a comprehensive replacement Product Disclosure Statement for seven Australian bond ETFs, updating key details on investment strategies, risks, fees, and regulatory frameworks.

LTR Pharma highlights SPONTAN's 5x faster absorption and validated safety, backed by over 1,000 Australian prescriptions and strategic partnerships as it targets FDA approval and US market entry.

AuKing Mining has locked in Thompson Resources to kick off a minimum 5,500m drilling campaign at its Tundulu Rare Earths project in Malawi, targeting structural extensions and depth continuity from mid-May 2026.

ANZ Group Holdings Limited posted a 14% rise in cash profit for 1H26 to AUD 3.78 billion, driven by cost reductions and steady revenue, while declaring an 83-cent interim dividend with 75% franking.

FBR Limited secured its first overseas Mantis welding robot sale, launched the Firehawk refractory robot, and expanded its Wall as a Service footprint in Victoria, while navigating a cash balance under $700,000.

Vanadium Resources (ASX: VR8) has taken major steps to commercialise its Steelpoortdrift project with a non-binding offtake deal with U.S. Vanadium and appointed Rand Merchant Bank to lead funding efforts.

GoldArc Resources has secured full ownership of Mt Stirling and launched partner-funded drilling campaigns across its Leonora North and South projects, delivering multiple high-grade gold results and locking in a binding development deal with Mineral Mining Services.

RareX Limited has advanced its rare earths ambitions by securing a key mining lease at Cummins Range, appointing a strategic board member, and raising $5 million to fund exploration and development.

Recce Pharmaceuticals bolsters its clinical and commercial pipeline with a $5.3 million AUD R&D tax rebate, a second U.S. Army research agreement for its RECCE 327 Gel, and a key patent granted in Brazil, while progressing Phase 3 trials in Indonesia.

Chariot Resources advances its Nigerian lithium acquisition with six licences transferred and spodumene confirmed in samples, while raising A$2.15 million and securing a A$3.5 million loan refinancing.